Skip to content

Transdiagnostic Internet-delivered Intervention for Adolescents With Anxiety and Depression

Transdiagnostic Internet-delivered Intervention for Adolescents With Anxiety and Depression

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06724666
Acronym
NEURO4C
Enrollment
198
Registered
2024-12-09
Start date
2025-04-01
Completion date
2026-06-30
Last updated
2025-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Disorders, Depressive Disorder, Dysthymia, Generalized Anxiety Disorder, Major Depressive Disorder, Social Anxiety Disorder

Keywords

Internet-delivered intervention, transdiagnostic, adolescents, internalizing, anxiety, depression

Brief summary

The goal of this clinical trial is to test the efficacy of a transdiagnostic Internet-delivered interventions for Romanian adolescents with anxiety and/ or depression. The main questions it aims to answer are: * What is the clinical efficacy of the Internet-delivered intervention? * How accurate is the prediction model in predicting who will respond to treatment? Participants will undergo non-invasive fMRI to measure variability in brain signal as a proxy of the neural systems' adaptability before receiving the intervention, then they will be allocated either to the Internet-delivered intervention or control group.

Detailed description

To the best of investigators' knowledge, this is the first clinical trial conducted with adolescents diagnosed with anxiety/and or depressive disorders that tests the accuracy of a prediction model based on fMRI to investigate participants' response to a transdiagnostic Internet-delivered intervention.

Interventions

BEHAVIORALTransdiagnostic Internet-delivered intervention

The intervention consists of 8 modules based on Rational emotive therapy, delivered via 8 weeks.

Sponsors

Babes-Bolyai University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
13 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* elevated symptoms of anxiety or depression/ internalizing problems (T score\> 60) at intake (based on Youth self-report completed by adolescents) * primary diagnosis of an anxiety/depressive disorder based on DSM-5 criteria according to ADIS-5-C/P interview * age 13-17 * able to read and understand Romanian language * Currently unmedicated or on stable and adequate doses of medication for at least 6 weeks before treatment onset * Internet access

Exclusion criteria

* severe mental disorder (psychosis, severe depression, bipolar disorder, based on clinical interview) * any condition that interferes with the protocol implementation (e.g., physical illness or sensory impairment that interferes with behavioral tasks such as exposure, behavioral activation, unavailable for the next 3 months), * active suicidal ideation (assessed by child psychiatrist during clinical interview) in the last month * currently following CBT/ psychotherapy for anxiety/depression, in the last 6 months * fMRI incompatible (based on safety questionnaire) * Being diagnosed with an intellectual disability, pervasive developmental disorder, an alcohol and/or substance dependence disorder, reading disabilities (based on clinical interview). * Current treatment with benzodiazepines

Design outcomes

Primary

MeasureTime frameDescription
Internalizing problemsbaseline, after 8 weeks of intervention, 6 months follow-upChange from baseline in internalizing problems. Revised Children's Anxiety and Depression Scale (RCADS) completed by adolescents.

Secondary

MeasureTime frameDescription
Anxiety and depressive symptomsbaseline, at each 2 weeks during treatment duration, after 8 weeks of intervention, 6 months follow-upPHQ4
Avoidancebaseline, after 8 weeks of intervention, 6 month follow-upCAMS
Parental distressbaselineDASS-21
Adolescent anxiety and depressive symptoms as reported by parentsbaseline, after 8 weeks of intervention, 6 month follow-upRCADS-47 parent report
Clinical diagnosisadministered pre-baseline, post-baseline (after 8 week waitlist period), after 8 weeks of interventionChange in DSM-5 Anxiety and Depressive Disorder Diagnoses in Accordance with Anxiety Disorders Interview Schedule for the DSM-5, Child and Parent Versions (ADIS-5-C/P) Clinical Diagnosis
Global functioningbaseline, after 8 weeks of intervention, 6 months follow-upChildren's Global Assessment Scale (C-GAS)
Severitybaseline, after 8 weeks of intervention, 6 months follow-upClinical Global Impression Scale - Severity
Credibility and expectations based on primary outcome measurebaselineCredibility and expectations based on primary outcome scale
Comorbid problemsbaseline, after 8 weeks of intervention, 6 month follow-upSubscales of the Revised Children's Anxiety and Depression Scale (RCADS) completed by adolescents
Life satisfactionbaseline, after 8 weeks of intervention, 6 months follow-upSWLS-C: Satisfaction with Life Scale for Children
Satisfaction with the Internet-delivered interventionafter 8 weeks of interventionClient Satisfaction Questionnaire (CSQ-8)
Working allianceafter 8 weeks of interventionWorking alliance scale for Internet interventions
Automatic thoughtsbaseline, after 8 weeks of intervention, 6 month follow-upAutomatic thoughts questionnaire
Credibility and expectationsweek 2Credibility and expectations questionnaire
Parental accommodationsbaselineFamily accommodation scale - parent report
Improvementafter 8 weeks of intervention, 6 months follow-upClinical Global Impression Scale - Improvement

Countries

Romania

Contacts

Primary ContactKristoffer Mansson, PhD
nils.mansson@ubbcluj.ro+46705803267

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026